SBPWG:Gaps: Difference between revisions
| Line 41: | Line 41: | ||
* Can we develop experimental systems for assessing safety? | * Can we develop experimental systems for assessing safety? | ||
* e.g. rE.Coli | * e.g. rE.Coli | ||
* e.g. http://trib.com/news/state-and-regional/article_6945effb-0af4-53ab-ba93-af79461f1535.html | |||
| Line 55: | Line 56: | ||
* e.g. FactCheck.org for synthetic biology as recommended by the PCSBI | * e.g. FactCheck.org for synthetic biology as recommended by the PCSBI | ||
* e.g. Climate Scientists Page: http://www.realclimate.org/ | * e.g. Climate Scientists Page: http://www.realclimate.org/ | ||
Risk Governance | Risk Governance | ||
* http://www.irgc.org/IMG/pdf/irgc_SB_final_07jan_web.pdf | * http://www.irgc.org/IMG/pdf/irgc_SB_final_07jan_web.pdf | ||
Revision as of 14:28, 30 June 2011
Introduction
We intend to use this space to seed, prioritize and sustain a list of 'Top 10 gaps' in our practice of synthetic biology for this group - and others - to consider, discuss, and work towards addressing. We ideally hope to produce from the discussions documented and materials collected here a series of simple, digestible co-authored papers summarizing each gap, current practices, open questions, and recommendations for moving forward.
Gaps to Mind
Please use this space to suggest and describe new or existing gaps, needs or issues in our practice of synthetic biology. Please add any relevant information, articles, contacts or other resources.
Gap Seed List
All these to be refined. Edit ruthlessly. Add comments, references, examples - anything that will be helpful!
Emergence of DIY & Implications for Safety, Security
- Should there be similar expectations of responsible conduct between institutional and non-institutional actors?
Preparedness for Syn Bio (-Labeled) Accidents
- Do we have a community response plan? Who will be held accountable?
- http://www.nature.com/nbt/journal/v27/n12/full/nbt1209-1109.html
Developing Trust in a World of Profits and Secrets
- How can we be ambassadors for biosafety when we do not have knowledge of research ongoing at private companies and in secure govt labs?
Ownership, Sharing and Innovation - Property Rights Frameworks for Synthetic Biology
- At what level in the abstraction hierarchy of envisioned biological designs should we instill property rights?
Educating and Inspiring Leadership in Pratices
- How savy should we expect researchers to be wrt the broader context of technology developments?
- How do deal with generational transfer of knowledge and immigration from a broad array of disciplines?
Testing Engineered Biological Designs in the 'Real World'
- What are appropriate risk assessment frameworks for intentional & unintentional environmental release?
- How do we approach regulation of cross-cutting technology platforms spanning multiple disjointed regulatory bodies set primarily by application area?
- Can we develop experimental systems for assessing safety?
- e.g. rE.Coli
- e.g. http://trib.com/news/state-and-regional/article_6945effb-0af4-53ab-ba93-af79461f1535.html
Economic Forecasting for Synthetic Biology Technology Developments
- What are our near-term vs long-term deliverables and how does syn bio fit into biotechnology developments at large?
Establishing Meaningful Dialogues with Diverse Stakeholders
- How can companies anticipate and respond proactively to public/soceital sentiments on biotechnology?
- e.g. ETC group letter to SB5
How can deliver reliable information about synthetic biology to the publics?
- e.g. FactCheck.org for synthetic biology as recommended by the PCSBI
- e.g. Climate Scientists Page: http://www.realclimate.org/
Risk Governance
